| Product Code: ETC11487826 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Japan's import of cannabinoids saw significant growth, with top exporters including the USA, Spain, Metropolitan France, Belgium, and Italy. The market continued to exhibit high concentration, as indicated by the high Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 stood at 2.35%, showing steady expansion. Notably, the growth rate from 2023 to 2024 spiked to 29.65%, reflecting a surge in demand for cannabinoids in Japan. This trend underscores the increasing importance and popularity of cannabinoids within the Japanese market.

The Japan cannabinoids market is experiencing significant growth driven by increasing awareness and acceptance of cannabis-derived products for medical and wellness purposes. The market is primarily dominated by CBD products due to their non-psychoactive properties and legal status in Japan. Key factors contributing to market expansion include the rising prevalence of chronic diseases, growing elderly population seeking alternative therapies, and the increasing adoption of cannabinoids in beauty and personal care products. The regulatory landscape in Japan is evolving, with the government allowing limited use of cannabinoids for medical and research purposes. However, strict regulations and societal stigma around cannabis continue to pose challenges for market growth. Overall, the Japan cannabinoids market shows promising potential, with opportunities for innovation and diversification across various industries.
The Japan cannabinoids market is experiencing a growing interest in CBD products, driven by increasing awareness of their potential health benefits and regulatory changes allowing for the sale of CBD products with low THC content. Consumers in Japan are seeking out CBD products for various purposes such as pain relief, stress management, and overall wellness. The market is witnessing a rise in the availability of CBD-infused products ranging from oils and tinctures to skincare and beverages. Additionally, there is a trend towards premium and high-quality CBD products, with an emphasis on transparency in sourcing and manufacturing processes. As the market continues to evolve, there is a growing opportunity for both domestic and international companies to capitalize on the demand for cannabinoids in Japan.
In the Japan cannabinoids market, one of the main challenges is the strict regulatory environment surrounding cannabis-derived products. While hemp-derived CBD is legal in Japan with certain restrictions, products containing THC are strictly prohibited. This regulatory framework creates uncertainty for businesses looking to enter the market and limits the variety of products available to consumers. Additionally, there is a lack of clear guidance on labeling requirements and quality standards for cannabinoids products, leading to confusion among both businesses and consumers. These regulatory challenges, coupled with cultural stigma surrounding cannabis, pose significant barriers to the growth and development of the cannabinoids market in Japan.
The Japan cannabinoids market presents promising investment opportunities due to recent regulatory changes allowing for the use of cannabinoids in certain products. With a growing interest in CBD products for health and wellness, there is a potential for significant market growth. Investors could consider opportunities in companies involved in the cultivation, extraction, and distribution of cannabinoids, as well as those focusing on research and development of innovative cannabinoid-based products tailored to the Japanese market. Additionally, investing in companies that provide testing services, regulatory consulting, and marketing solutions for cannabinoid products could also be lucrative. Given the evolving regulatory landscape and increasing consumer acceptance, the Japan cannabinoids market offers a diverse range of investment possibilities for those looking to capitalize on the growing demand for cannabinoid products.
In Japan, the use and possession of cannabinoids, including marijuana, are strictly regulated and illegal under the Cannabis Control Law. The law prohibits the production, distribution, and possession of marijuana, with severe penalties for violators, including imprisonment and fines. However, the government has allowed limited research on cannabinoids for medical purposes under strict regulations. In 2015, Japan approved clinical trials for the use of CBD oil to treat epilepsy, marking a small step towards potential medical applications of cannabinoids in the country. Despite the growing global trend towards legalization and regulation of cannabinoids, Japan maintains a conservative stance on the issue, with strict enforcement and limited access to cannabinoids for medical research purposes only.
The future outlook for the Japan cannabinoids market is promising, with increasing acceptance and legalization of medical cannabis in the country. As the Japanese government continues to explore the potential benefits of cannabinoids for various health conditions, including chronic pain and epilepsy, the market is expected to experience significant growth. With a growing aging population and rising awareness of alternative medicine, there is a growing demand for cannabinoid-based products in Japan. However, strict regulations and cultural attitudes towards cannabis may still pose challenges to market expansion. Overall, the Japan cannabinoids market is poised for growth as more research is conducted, and regulations become more favorable towards cannabinoid products.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Cannabinoids Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Cannabinoids Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Cannabinoids Market - Industry Life Cycle |
3.4 Japan Cannabinoids Market - Porter's Five Forces |
3.5 Japan Cannabinoids Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Japan Cannabinoids Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Japan Cannabinoids Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Japan Cannabinoids Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Japan Cannabinoids Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Japan Cannabinoids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the potential health benefits of cannabinoids in Japan |
4.2.2 Growing acceptance of medical cannabis in Japan |
4.2.3 Rise in research and development activities related to cannabinoids in Japan |
4.3 Market Restraints |
4.3.1 Stringent regulations and legal restrictions surrounding the use of cannabinoids in Japan |
4.3.2 Lack of standardized quality control measures in the production of cannabinoids |
4.3.3 Limited availability of product variety and distribution channels for cannabinoids in Japan |
5 Japan Cannabinoids Market Trends |
6 Japan Cannabinoids Market, By Types |
6.1 Japan Cannabinoids Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Cannabinoids Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Japan Cannabinoids Market Revenues & Volume, By CBD, 2021 - 2031F |
6.1.4 Japan Cannabinoids Market Revenues & Volume, By THC, 2021 - 2031F |
6.1.5 Japan Cannabinoids Market Revenues & Volume, By CBG, 2021 - 2031F |
6.2 Japan Cannabinoids Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Cannabinoids Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.3 Japan Cannabinoids Market Revenues & Volume, By Appetite Stimulation, 2021 - 2031F |
6.2.4 Japan Cannabinoids Market Revenues & Volume, By Skin Health, 2021 - 2031F |
6.3 Japan Cannabinoids Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Japan Cannabinoids Market Revenues & Volume, By Consumers, 2021 - 2031F |
6.3.3 Japan Cannabinoids Market Revenues & Volume, By Patients, 2021 - 2031F |
6.3.4 Japan Cannabinoids Market Revenues & Volume, By E-commerce, 2021 - 2031F |
6.4 Japan Cannabinoids Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Japan Cannabinoids Market Revenues & Volume, By Cannabis, 2021 - 2031F |
6.4.3 Japan Cannabinoids Market Revenues & Volume, By Hemp, 2021 - 2031F |
6.4.4 Japan Cannabinoids Market Revenues & Volume, By Plant-Based, 2021 - 2031F |
6.5 Japan Cannabinoids Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Japan Cannabinoids Market Revenues & Volume, By Nanoemulsion, 2021 - 2031F |
6.5.3 Japan Cannabinoids Market Revenues & Volume, By Microencapsulation, 2021 - 2031F |
6.5.4 Japan Cannabinoids Market Revenues & Volume, By Advanced Extraction, 2021 - 2031F |
7 Japan Cannabinoids Market Import-Export Trade Statistics |
7.1 Japan Cannabinoids Market Export to Major Countries |
7.2 Japan Cannabinoids Market Imports from Major Countries |
8 Japan Cannabinoids Market Key Performance Indicators |
8.1 Number of clinical trials conducted on cannabinoids in Japan |
8.2 Percentage increase in the issuance of licenses for cannabinoid research and production in Japan |
8.3 Growth in the number of medical professionals prescribing cannabinoids in Japan. |
9 Japan Cannabinoids Market - Opportunity Assessment |
9.1 Japan Cannabinoids Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Japan Cannabinoids Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Japan Cannabinoids Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Japan Cannabinoids Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Japan Cannabinoids Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Japan Cannabinoids Market - Competitive Landscape |
10.1 Japan Cannabinoids Market Revenue Share, By Companies, 2024 |
10.2 Japan Cannabinoids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here